DAVITA INC. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
DAVITA INC. (DVA) reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of $1.39 billion for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2019-11-07
- DAVITA INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2019-09-30 was $640.71M, a 39.99% increase year-over-year.
- DAVITA INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2019-06-30 was $609.81M, a 8.50% increase year-over-year.
- DAVITA INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2019-03-31 was $141.30M, a 61.02% decline year-over-year.
- DAVITA INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2018-09-30 was $457.67M, a 17.25% decline year-over-year.
- DAVITA INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was $1.96B, a 26.09% increase from fiscal 2015.
- DAVITA INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was $1.56B, a 6.70% increase from fiscal 2014.
- DAVITA INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was $1.46B, a 17.70% decline from fiscal 2013.
- DAVITA INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2013 was $1.77B.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|---|---|
| 2019-09-30 | $640.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.25B derived: sum of 2 quarters · filed 2019-11-07 | $1.39B 10-Q · filed 2019-11-07 | ||||
| 2019-06-30 | $609.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $751.12M 10-Q · filed 2019-08-02 | |||||
| 2019-03-31 | $141.30M 10-Q · filed 2019-05-07 | ||||||
| 2018-09-30 | $457.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.02B derived: sum of 2 quarters · filed 2019-11-07 | $1.38B 10-Q · filed 2019-11-07 | ||||
| 2018-06-30 | $562.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $924.58M 10-Q · filed 2019-08-02 | |||||
| 2018-03-31 | $362.54M 10-Q · filed 2019-05-07 | ||||||
| 2017-09-30 | $553.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $702.98M derived: sum of 2 quarters · filed 2018-11-07 | $1.57B 10-Q · filed 2018-11-07 | $1.56B 10-Q · filed 2017-11-07 | $2.05B derived: sum of 4 quarters · filed 2018-11-07 | ||
| 2017-06-30 | $149.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $1.02B 10-Q · filed 2018-08-01 | $1.01B 10-Q · filed 2017-08-01 | $1.50B derived: sum of 3 quarters · filed 2018-08-01 | $2.03B derived: sum of 4 quarters · filed 2018-08-01 | ||
| 2017-03-31 | $865.17M 10-Q · filed 2018-05-03 | $865.17M 10-Q · filed 2017-05-02 | $1.35B derived: sum of 2 quarters · filed 2018-05-03 | $1.88B derived: sum of 3 quarters · filed 2018-05-03 | $2.40B derived: sum of 4 quarters · filed 2018-05-03 | ||
| 2016-12-31 | $482.18M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $1.02B derived: sum of 2 quarters · filed 2017-11-07 | $1.53B derived: sum of 3 quarters · filed 2017-11-07 | $1.96B 10-K · filed 2017-02-24 | |||
| 2016-09-30 | $535.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.05B derived: sum of 2 quarters · filed 2017-11-07 | $1.48B 10-Q · filed 2017-11-07 | $1.92B derived: sum of 4 quarters · filed 2017-11-07 | |||
| 2016-06-30 | $516.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $945.64M 10-Q · filed 2017-08-01 | $1.38B derived: sum of 3 quarters · filed 2017-08-01 | $2.06B derived: sum of 4 quarters · filed 2017-08-01 | |||
| 2016-03-31 | $429.00M 10-Q · filed 2017-05-02 | $865.67M derived: sum of 2 quarters · filed 2017-05-02 | $1.54B derived: sum of 3 quarters · filed 2017-05-02 | $1.58B derived: sum of 4 quarters · filed 2017-05-02 | |||
| 2015-12-31 | $436.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $1.12B derived: sum of 2 quarters · filed 2017-02-24 | $1.15B derived: sum of 3 quarters · filed 2017-02-24 | $1.56B 10-K · filed 2017-02-24 | |||
| 2015-09-30 | $679.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $710.44M derived: sum of 2 quarters · filed 2016-11-02 | $1.12B 10-Q · filed 2016-11-02 | $1.05B derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2015-06-30 | $31.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $441.53M 10-Q · filed 2016-08-08 | $371.54M derived: sum of 3 quarters · filed 2017-02-24 | $1.22B derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2015-03-31 | $410.09M 10-Q · filed 2016-05-04 | $340.10M derived: sum of 2 quarters · filed 2017-02-24 | $1.19B derived: sum of 3 quarters · filed 2017-02-24 | ||||
| 2014-12-31 | -$69.99M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $777.91M derived: sum of 2 quarters · filed 2017-02-24 | $1.46B 10-K · filed 2017-02-24 | ||||
| 2014-09-30 | $847.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $1.53B 10-Q · filed 2015-11-05 | |||||
| 2014-06-30 | $681.50M 10-Q · filed 2015-08-05 | ||||||
| 2013-12-31 | $1.77B 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |